BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis

Br J Dermatol. 2019 Apr;180(4):933-934. doi: 10.1111/bjd.17420. Epub 2018 Dec 27.

Authors

F Bellinato¹, M Maurelli¹, C Colato², R Balter³, G Girolomoni¹, D Schena¹

Affiliations

¹ Section of Dermatology and Venereology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126, Verona, Italy.
² Section of Pathology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
³ UOC Oncoematologia Pediatrica, Ospedale della Donna e del Bambino, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

PMID: 30430550
DOI: 10.1111/bjd.17420

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Asymptomatic Diseases
Dermoscopy
Histiocytosis, Langerhans-Cell / complications*
Histiocytosis, Langerhans-Cell / drug therapy
Histiocytosis, Langerhans-Cell / genetics
Humans
Male
Mutation
Proto-Oncogene Proteins B-raf / genetics*
Skin / diagnostic imaging
Skin / pathology
Xanthogranuloma, Juvenile / diagnosis
Xanthogranuloma, Juvenile / genetics*
Xanthogranuloma, Juvenile / pathology

Substances

BRAF protein, human
Proto-Oncogene Proteins B-raf